These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 15778113
1. Laboratory markers associated with progression of HIV infection. Kiepiela P, Smith AN, Rosenberg E. Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):243-54. PubMed ID: 15778113 [Abstract] [Full Text] [Related]
4. Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease. Sterling TR, Hoover DR, Astemborski J, Vlahov D, Bartlett JG, Schupbach J. J Infect Dis; 2002 Oct 15; 186(8):1181-5. PubMed ID: 12355373 [Abstract] [Full Text] [Related]
5. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection. Mildvan D, Spritzler J, Grossberg SE, Fahey JL, Johnston DM, Schock BR, Kagan J. Clin Infect Dis; 2005 Mar 15; 40(6):853-8. PubMed ID: 15736019 [Abstract] [Full Text] [Related]
6. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection]. Antón F, Labarga P, Pinilla J, Soto MJ, Leoz A, del Cura J, Borque L, Milazzo A. Enferm Infecc Microbiol Clin; 1993 Mar 15; 11(7):373-7. PubMed ID: 8104488 [Abstract] [Full Text] [Related]
8. Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS. Blattner WA, Oursler KA, Cleghorn F, Charurat M, Sill A, Bartholomew C, Jack N, O'Brien T, Edwards J, Tomaras G, Weinhold K, Greenberg M. J Infect Dis; 2004 May 15; 189(10):1793-801. PubMed ID: 15122515 [Abstract] [Full Text] [Related]
12. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. Goujard C, Bonarek M, Meyer L, Bonnet F, Chaix ML, Deveau C, Sinet M, Galimand J, Delfraissy JF, Venet A, Rouzioux C, Morlat P, Agence Nationale de Recherche sur le Sida PRIMO Study Group. Clin Infect Dis; 2006 Mar 01; 42(5):709-15. PubMed ID: 16447119 [Abstract] [Full Text] [Related]
16. A decade of research on the natural history of HIV infection: Part 1. Markers. Strathdee SA, O'Shaughnessy MV, Montaner JS, Schechter MT. Clin Invest Med; 1996 Apr 01; 19(2):111-20. PubMed ID: 8697670 [Abstract] [Full Text] [Related]
17. C-reactive protein is a marker for human immunodeficiency virus disease progression. Lau B, Sharrett AR, Kingsley LA, Post W, Palella FJ, Visscher B, Gange SJ. Arch Intern Med; 2006 Jan 09; 166(1):64-70. PubMed ID: 16401812 [Abstract] [Full Text] [Related]
18. UCLA researcher demonstrates new ways to assess drug treatment in HIV-infected patients. AIDS Patient Care STDS; 1996 Jun 09; 10(3):189-90. PubMed ID: 11361638 [No Abstract] [Full Text] [Related]
19. [Neopterin--a prognostic marker in HIV infection]. Breustedt W, Rabe H, Volk D, Porstmann P. Dermatol Monatsschr; 1989 Jun 09; 175(4):226-31. PubMed ID: 2499491 [Abstract] [Full Text] [Related]
20. Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers. Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H. Scand J Immunol; 2008 Dec 09; 68(6):652-60. PubMed ID: 19055701 [Abstract] [Full Text] [Related] Page: [Next] [New Search]